Inactive Instrument
Complete Genomics, Inc. Stock
Stocks
US20454K1043
Advanced Medical Equipment & Technology
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Yongwei Zhang
CEO | Chief Executive Officer | - | - |
Robert Curson
PRN | Corporate Officer/Principal | 83 | 2010-11-15 |
Radoje Drmanac
CTO | Chief Tech/Sci/R&D Officer | 68 | 2005-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.07% | -8.23% | -4.96% | +18.46% | 42.23B | |
| -2.62% | -7.04% | -45.87% | +121.93% | 12.54B | |
| +0.70% | -1.38% | -11.32% | +74.67% | 5.71B | |
| -2.53% | -8.49% | +35.87% | - | 4.06B | |
| -0.84% | -5.81% | - | - | 1.99B | |
| -4.13% | -7.38% | +1.22% | -39.91% | 1.53B | |
| +0.30% | -5.41% | -34.96% | - | 1.06B | |
| -0.97% | 0.00% | +10.82% | +143.81% | 1.02B | |
| -2.29% | -8.69% | +36.90% | +43.46% | 923M | |
| Average | -1.42% | -3.65% | -1.54% | +60.40% | 7.9B | |
| Weighted average by Cap. | -0.75% | -6.22% | -10.04% | +44.74% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
